Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2023

Summary of Significant Accounting Policies [Abstract]

Schedule of Accounts and Grants Receivable

Accounts and grants receivable by source, as of (in thousands):

	December 31,
	2023		2022
National Institutes of Health – Grant	$	96	$	218
Accounts receivable from customers		15		-
Total	$	111	$	218

Schedule of Revenue

Revenue by source (in thousands):

	Years ended December 31,
	2023		2022
National Institute of Health - grant	$	41	$	164
Clinical trial revenue		668		940
MSCRF – TEDCO1 - grant		-		118
Total	$	709	$	1,222

¹ Maryland Stem Cell Research Fund (MSCRF) - Maryland Technology Development Corporation (TEDCO)